Business
Navigating the Long Road to FDA Approval: Insights from BioticsAI CEO
AI Summary
Building a medtech startup requires more than great technology; it demands team motivation, right investors, and adaptability during uncertain timelines. Robhy Bustami, CEO of BioticsAI, shares insights on surviving the long road to FDA approval.
The Challenges of FDA Approval
Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain.Lessons from BioticsAI
This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building an AI copilot for ultrasound to help detect fetal abnormalities. From a $100,000 prototype to FDA clearance, Bustami shares what it actually takes to build in one of the most regulated industries in the world.Building a Medtech Startup
In this episode, they break down what it really looks like to build a medtech startup, including where you can’t “move fast and break things” and that every milestone takes time, coordination, and trust.Key Takeaways
- Team motivation is crucial during the long FDA approval process
- Finding the right investors is essential for medtech startups
- Adaptability is key when dealing with uncertain timelines